NEW YORK, Nov. 1 (GenomeWeb News) - Caliper today reported a 5.7-percent year-over-year revenue increase for the third quarter. The Hopkinton, Mass.-based biotech also narrowed its net loss by 25 percent.
For the quarter ended Sept. 30, Caliper reported revenues of $21.3 million, compared to $20.2 million in the third quarter of 2004. Of this, approximately $15.8 million was product revenue, while the rest resulted from service, contract, and license fees.
The company spent $4.2 million on R&D in the period, down from $5.2 million year over year.
Caliper's net losses for the quarter decreased to $3.9 million from $5.1 million in the same quarter last year.
As of Sept. 30, Caliper had cash, cash equivalents, and marketable securities of $34.8 million.